Fieldpoint Private Advisors’s Merck MRK Stock Holding History

Fieldpoint Private Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-262	Closed	-$16K	–	12
2017 Q2	$16K	Buy	+262	New	+$15.9K	0.83%	25

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fieldpoint Private Advisors's MRK Position: Q3 2017 in Review

Fieldpoint Private Advisors sold out of Merck (MRK) in Q3 2017, closing a stake of 262 shares — an estimated $16K sold.

Fieldpoint Private Advisors first reported a position in MRK in Q2 2017 and held it in 1 quarter. The position peaked at $16K in Q2 2017. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

Fieldpoint Private Advisors reported no remaining Merck position as of Q3 2017 after selling out during the quarter.
Fieldpoint Private Advisors sold 262 Merck shares in Q3 2017, an estimated $16K.
Fieldpoint Private Advisors first reported a position in Merck in Q2 2017 and held it in 1 quarter.
Fieldpoint Private Advisors's Merck position peaked at $16K in Q2 2017.
1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Fieldpoint Private Advisors's 13F filing for Q3 2017.